Abstract
Sisomicin, at 4.5 mg/kg per day, was prescribed for the therapy of serious bacterial infections of hospitalized infants, children, and adolescents. Eleven children received full treatment courses, with 10 clinical and 9 bacteriological cures. Three patients with underlying disease (two cystic fibrosis and one aplastic anemia) accounted for the failures. Mean half-life was 98.3 min (range, 26.1 to 159.3), and peak serum concentrations 10 min after intravenous infusion were similar (5 to 6 μg/ml) on days 1, 3, and 5 of therapy. Mean urinary concentrations were 54.3 μg/ml; 31 to 47% of the drug was excreted within the 8-h dosage interval. The drug was tolerated well by all patients; however, one patient, receiving the longest duration of therapy (26 days), developed reversible nephrotoxicity.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klastersky J., Hensgens C., Gerard M., Daneau D. Comparison of sisomicin and gentamicin in bacteriuric patients with underlying diseases of the urinary tract. Antimicrob Agents Chemother. 1975 Jun;7(6):742–747. doi: 10.1128/aac.7.6.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klastersky J., Hensgens C., Gérad M., Daneau D. Sisomicin: Bacteriological and clinical evaluation. J Clin Pharmacol. 1975 Apr;15(4 Pt 1):252–261. doi: 10.1002/j.1552-4604.1975.tb01445.x. [DOI] [PubMed] [Google Scholar]
- Klastersky J., Nyamubeya B., Vandenborre L. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods. J Med Microbiol. 1974 Nov;7(4):465–472. doi: 10.1099/00222615-7-4-465. [DOI] [PubMed] [Google Scholar]
- Marks M. I., Hammerberg S., Greenstone G., Silver B. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1976 Sep;10(3):399–401. doi: 10.1128/aac.10.3.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meunier-Carpentier F., Staquet M., Klastersky J. Comparative study of three routes of administration of sisomicin. J Clin Pharmacol. 1976 Nov-Dec;16(11-12):625–630. doi: 10.1002/j.1552-4604.1976.tb01501.x. [DOI] [PubMed] [Google Scholar]
- Meyers B. R., Hirschman S. Z., Yancovitz S., Ribner B. Pharmacokinetic parameters of sisomicin. Antimicrob Agents Chemother. 1976 Jul;10(1):25–27. doi: 10.1128/aac.10.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meyers B. R., Leng B., Hirschman S. Z. Comparison of the antibacterial activities of sisomicin and gentamicin against gram-negative bacteria. Antimicrob Agents Chemother. 1975 Dec;8(6):757–758. doi: 10.1128/aac.8.6.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pechère J. C., Pechère M. M., Dugal R. Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients. Antimicrob Agents Chemother. 1976 May;9(5):761–765. doi: 10.1128/aac.9.5.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodriguez V., Bodey G. P., Valdivieso M., Feld R. Clinical pharmacology of sisomicin. Antimicrob Agents Chemother. 1975 Jan;7(1):38–41. doi: 10.1128/aac.7.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stewart D., Bodey G. P. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates. J Antibiot (Tokyo) 1975 Feb;28(2):149–155. doi: 10.7164/antibiotics.28.149. [DOI] [PubMed] [Google Scholar]
- Welling P. G., Mosegaard A., Madsen P. O. Sisomicin treatment of complicated urinary tract infections: efficacy, tolerance and pharmacokinetics. J Clin Pharmacol. 1974 Oct;14(10):567–573. doi: 10.1002/j.1552-4604.1974.tb01372.x. [DOI] [PubMed] [Google Scholar]